Lucira Health, Inc. (LHDX) Misses Q2 EPS by 9c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/15/2026

1. NVDA
2. DPZ
3. DRS
4. GS
5. BAC
6. UNH
7. ORCL
8. AVAV
9. ACI
10. LMT

Go back to Lucira Health, Inc. (LHDX) Misses Q2 EPS by 9c

Lucira Health Announces Second Quarter 2022 Results and Provides Business Updates

August 15, 2022 4:01 PM EDT

EMERYVILLE, Calif., Aug. 15, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (Nasdaq: LHDX) ("Lucira Health," "Lucira" or the "Company"), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease tests, today reported financial results for the second quarter ended June 30, 2022 and provided business updates.

Recent Highlights

Achieved net revenue of $26.1 million for the second quarter of 2022, an increase of 110% over the second quarter of 2021... More